Selected growth factors in peritoneal dialysis: Their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport

Peritoneal Dialysis International

Volumn 22, Issue 6, 2002, Pages 670-676

  Stompór, Tomasz ^a   Zdzienicka, Anna ^a   Motyka, Marcin ^a   Dembińska Kieć, Aldona ^a   Davies, Simon J ^b   Sulowicz, Wladyslaw ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Acute phase response; Growth factors; Residual renal function

Indexed keywords

ACUTE PHASE PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; C REACTIVE PROTEIN; FIBRINOGEN; GROWTH FACTOR; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MEMBRANE TRANSPORT; NEPHELOMETRY; PERITONEAL DIALYSIS; PERITONITIS; POLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 12244299209     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200605     Document Type: Article

References (34)

1. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 2000; 18:183-90.
2. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-60.
3. Bergström J, Lindholm B. Malnutrition, cardiac disease and mortality: an integrated point of view. Am J Kidney Dis 1998; 32:834-41.
4. Koenig W, Wanner C. C-reactive protein and coronary disease - what is the link? Nephrol Dial Transplant 1999; 14:2798-9.
5. Luzzio G, Luigi M, Gallimore JG, Grillo RL, Rebuzzi A, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-24.
6. Alexander RW. Inflammation and coronary heart disease. N Engl J Med 1994; 331:468-9.
7. Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55:648-58.
8. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-6.
9. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993; 92:2408-18.
10. Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res 1999; 84:323-8.
11. Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M, et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 1997; 59:133-8.
12. Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994; 23:193-8.
13. Jones SG, Morrisey K, Williams JD, Phillips AO. TGF-beta1 stimulates the release of pre-formed bFGF from renal proximal tubular cells. Kidney Int 1999; 56:83-91.
14. Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Physiol 2000; 278:F554-60.
15. Noronha IL, Fujihara CK, Zatz R. The inflammatory component in progressive renal disease - are interventions possible? Nephrol Dial Transplant 2002; 17:363-8.
16. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 17: 2108-17.
17. Chen XX, Nakashima Y, Tanaka K, Shiraishi S, Nakagawa K, Sueishi K. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Atheroscler Thromb Vasc Biol 1999; 19:131-9.
18. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects of membrane function. J Am Soc Nephrol 2001; 12:2029-39.
19. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT. Growth factors VEGF and TGFβ1 in peritoneal dialysis. J Lab Clin Med 1999; 134:124-32.
20. Medcalf JF, Walls J, Pawluczyk IZA, Harris KPG. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-β. Nephrol Dial Transplant 2001; 16: 1885-92.
21. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-39.
22. Twardowski ZJ, Nolph KD, Khanna R. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
23. Twardowski ZJ. Clinical value of standardized equilibration test in CAPD patients. Blood Purif 1989; 7:95-108.
24. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61:570-8.
25. Wang T, Heimbürger O, Cheng HH, Bergström J, Lindholm B. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999; 19:17-22.
26. Espinoza M, Aguilera A, Auxiliadora Bajo M, Codoceo R, Caravaca E, et al. Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients. Adv Perit Dial 1999; 15: 82-6.
27. Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16:2240-5.
28. Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 1997; 77: 13-28.
29. Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-β1 of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit Dial Int 1999; 19:221-30.
30. Ogata S, Yorioka N, Kohno N. Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 2001; 12:2787-96.
31. Park MS, Cha JH, Kim SI, Passlick-Deetjen J. High glucose dialysis solutions increased VEGF synthesis by peritoneal vascular endothelial cells (Abstract). Perit Dial Int 2001; 21(Suppl 2):S23.
32. Wieslander A, Linden T, Musi B, Carlsson O, Deppisch R. Biological significance of reducing glucose degradation products in peritoneal dialysis fluid. Perit Dial Int 2000; 20(Suppl 5):S23-7.
33. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in peritoneal membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
34. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97:645-50.